Dose relationship between oral glucocorticoids and tumor necrosis factor inhibitors and the risk of hospitalized infectious events among patients with rheumatoid arthritis

The objective of this study was to evaluate the impact of oral glucocorticoid (GC) dose on rates of hospitalized infectious events (HIEs) among RA patients newly exposed to tumor necrosis factor inhibitor (TNFi) therapy. This retrospective cohort study used data from the MarketScan claims database....

Descripción completa

Detalles Bibliográficos
Autores principales: Schenfeld, Jennifer, Iles, Jan, Trivedi, Mona, Accortt, Neil A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Safety
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486791/
https://www.ncbi.nlm.nih.gov/pubmed/28255642
http://dx.doi.org/10.1007/s00296-017-3679-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486791/
https://www.ncbi.nlm.nih.gov/pubmed/28255642
http://dx.doi.org/10.1007/s00296-017-3679-4

Ejemplares similares